Using Biometric ID to improve malaria vaccine completion
Part of Infections clinical trials.
This study is testing a new way to use biometric identification (like fingerprints) to help make sure women get all doses of the malaria vaccine. It is for pregnant women or new mothers who plan to stay in the area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 15 and 49 years old
- You are either pregnant (in your last two trimesters) or have a child younger than 6 months
- You do not plan to move away permanently in the next 12 months
- You are able to give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lab tests for malaria vaccine candidates in pregnant women who currently have malaria. It may help researchers understand which vaccine approaches are safest and most promising for pregnancy.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This study is testing a mobile health (mHealth) program to improve childhood vaccination rates among displaced families in conflict-affected areas of Nigeria. If you are a caregiver for a young child or pregnant, living in an IDP camp, you may be able to help researchers see if a phone-based tool makes it easier to get vaccines on time.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
Hear when a new Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.